Revenues

12 Months Ended

Dec. 31, 2024

Revenue from Contract with Customer [Abstract]

Revenues

Note 2. Revenues

As discussed in Note 1, revenues are recognized under guidance within ASC 606. The following table presents our disaggregated revenue for the periods presented (in thousands):

	For the Years Ended, December 31,
	2024		2023		2022
JAKAFI revenues, net	$	2,792,107	$	2,593,732	$	2,409,225
OPZELURA revenues, net	508,293		337,864		128,735
ICLUSIG revenues, net	114,319		111,623		105,838
MINJUVI/MONJUVI revenues, net	119,236		37,057		19,654
PEMAZYRE revenues, net	81,748		83,642		83,445
ZYNYZ revenues, net	3,185		1,250		—
Total product revenues, net	3,618,888		3,165,168		2,746,897
JAKAVI product royalty revenues	418,840		367,583		331,575
OLUMIANT product royalty revenues	135,572		136,138		134,547
TABRECTA product royalty revenues	22,746		17,793		15,411
PEMAZYRE product royalty revenues	2,171		1,967		1,205
Total product royalty revenues	579,329		523,481		482,738
Milestone and contract revenues	43,000		7,000		165,000
Total revenues	$	4,241,217	$	3,695,649	$	3,394,635

For further information on our revenue-generating contracts, refer to Note 7.